The effect of topiramate on tumor-related angiogenesis and on the serum proteome of mice bearing Lewis lung carcinoma

European Journal of Pharmacology

Volumn 663, Issue 1-3, 2011, Pages 9-16

  Ma, Bing ^a,c   Pan, Yan ^a   Song, Qianliu ^a   Tie, Lu ^a   Zhang, Ye ^a   Xiao, Yuan ^a   Zhang, Jianzhao ^a   Han, Jing ^a   Xu, Yan ^a   Xiang, Yang ^a   Yu, He Ming ^b   Li, Xue Jun ^a  

^a PEKING UNIVERSITY HEALTH SCIENCE CENTER   (China)

^b NATIONAL RESEARCH INSTITUTE FOR FAMILY PLANNING   (China)

^c BEIJING INSTITUTE OF TECHNOLOGY   (China)

Author keywords

Angiogenesis; Carbonic anhydrase II; Osteopontin; Topiramate; Tumor metastasis; VEGF

Indexed keywords

CARBONATE DEHYDRATASE II; CARBONATE DEHYDRATASE IX; MESSENGER RNA; OSTEOPONTIN; PREALBUMIN; PROTEOME; SERUM AMYLOID A; TOPIRAMATE; TROPOMYOSIN; VASCULOTROPIN; VITRONECTIN RECEPTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIANGIOGENIC ACTIVITY; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER INHIBITION; CHICKEN; CONTROLLED STUDY; DISEASE SEVERITY; DOSE RESPONSE; DOWN REGULATION; DRUG DOSE COMPARISON; DRUG MECHANISM; EMBRYO; FEMALE; FUNCTIONAL PROTEOMICS; GENE EXPRESSION REGULATION; LEWIS CARCINOMA; METASTASIS; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN DETERMINATION; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; TUMOR VASCULARIZATION; TWO DIMENSIONAL GEL ELECTROPHORESIS;

ANIMALS; ANTINEOPLASTIC AGENTS; BLOOD PROTEINS; CARBONIC ANHYDRASE II; CARCINOMA, LEWIS LUNG; CHORIOALLANTOIC MEMBRANE; DOWN-REGULATION; FEMALE; FRUCTOSE; GENE EXPRESSION REGULATION, NEOPLASTIC; INTEGRIN ALPHAVBETA3; MICE; MICE, INBRED C57BL; NEOPLASM METASTASIS; NEOVASCULARIZATION, PATHOLOGIC; OSTEOPONTIN; PROTEOME; PROTEOMICS; PULMONARY ALVEOLI; RNA, MESSENGER; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 79959321047     PISSN: 00142999     EISSN: 18790712     Source Type: Journal    
DOI: 10.1016/j.ejphar.2011.04.056     Document Type: Article

References (28)

1. Braga, M.F., Aroniadou-Anderjaska, V., Li, H., Rogawski, M.A., 2009. Topiramate reduces excitability in the basolateral amygdala by selectively inhibiting GluK1 (GluR5) kainate receptors on interneurons and positively modulating GABAA receptors on principal neurons. J. Pharmacol. Exp. Ther 330, 558-566.
2. Chakraborty, G., Jain, S., Kundu, G.C., 2008. Osteopontin promotes vascular endothelial growth factor-dependent breast tumor growth and angiogenesis via autocrine and paracrine mechanisms. Cancer Res. 68, 152-161. (Pubitemid 351380116)
3. Choueiri, T.K., Regan, M.M., Rosenberg, J.E., Oh, W.K., Clement, J., Amato, A.M., McDermott, D., Cho, D.C., Atkins, M.B., Signoretti, S., 2010. Carbonic anhydrase IX and pathological features as predictors of outcome in patients with metastatic clear-cell renal cell carcinoma receiving vascular endothelial growth factor-targeted therapy. B.J.U. Int 106, 772-778.
4. Cui, R., Takahashi, F., Ohashi, R., Gu, T., Yoshioka, M., Nishio, K., Ohe, Y., Tominaga, S., Takagi, Y., Sasaki, S., Fukuchi, Y., Takahashi, K., 2007. Abrogation of the interaction between osteopontin and alphavbeta3 integrin reduces tumor growth of human lung cancer cells in mice. Lung Cancer 57, 302-310. (Pubitemid 47285419)
5. Cui, R., Takahashi, F., Ohashi, R., Yoshioka, M., Gu, T., Tajima, K., Unnoura, T., Iwakami, S., Hirama, M., Ishiwata, T., Iwase, A., Takahashi, K., 2009. Osteopontin is involved in the formation of malignant pleural effusion in lung cancer. Lung Cancer 63, 368-374.
6. Dorai, T., Sawczuk, I.S., Pastorek, J., Wiernik, P.H., Dutcher, J.P., 2005. The role of carbonic anhydrase IX overexpression in kidney cancer. Eur. J. Cancer 41, 2935-2947. (Pubitemid 41713134)
7. Haapasalo, J., Nordfors, K., Järvelä, S., Bragge, H., Rantala, I., Parkkila, A.K., Haapasalo, H., Parkkila, S., 2007. Carbonic anhydrase II in the endothelium of glial tumors: a potential target for therapy. Neuro-Oncol. 9, 308-313. (Pubitemid 47169663)
8. Hui, E.P., Chan, A.T., Pezzella, F., Turley, H., To, K.F., Poon, T.C., Zee, B., Mo, F., Teo, P.M., Huang, D.P., Gatter, K.C., Johnson, P.J., Harris, A.L., 2002. Coexpression of hypoxia-inducible factors 1alpha and 2alpha, carbonic anhydrase IX, and vascular endothelial growth factor in nasopharyngeal carcinoma and relationship to survival. Clin. Cancer Res. 8, 2595-2604.
9. Ma, B., Xiang, Y., Li, T., Yu, H.M., Li, X.J., 2004. Inhibitory effect of topiramater on Lewis lung carcinoma metastasis and its relation with AQP1 water channel. Acta Pharmacol. Sin. 25, 54-60.
10. Maschio, M., Dinapoli, L., Zarabia, A., Jandolo, B., 2006. Issues related to the pharmacological management of patients with brain tumours and epilepsy. Funct. Neurol. 21, 15-19.
11. Maschio, M., Dinapoli, L., Zarabla, A., Pompili, A., Carapella, C.M., Pace, A., Giannarelli, D., Occhipinti, E., Jandolo, B., 2008. Outcome and tolerability of topiramate in brain tumor associated epilepsy. J. Neurooncol. 86, 61-70. (Pubitemid 350263434)
12. Nemoto, H., Rittling, S.R., Yoshitake, H., Furuya, K., Amagasa, T., Tsuji, K., Nifuji, A., Denhardt, D.T., Noda, M., 2001. Osteopontin deficiency reduces experimental tumor cell metastasis to bone and soft tissues. J. Bone Miner. Res. 16, 652-659.
13. Noble, J.E., Bailey, M.J., 2009. Quantitation of protein. Methods Enzymol. 463, 73-95.
14. Pan, Y., Song, Q.L., Lin, Y.H., Lu, N., Yu, H.M., Li, X.J., 2005. GLB prevents tumor metastasis of Lewis lung carcinoma by inhibiting tumor adhesion actions. Acta Pharmacol. Sin. 26, 881-886.
15. Pan, P., Leppilampi, M., Pastorekova, S., Pastorek, J., Waheed, A., Sly, W.S., Parkkila, S., 2006. Carbonic anhydrase gene expression in CA II-deficient (Car2-/-) and CAIX-deficient (Car9-/-) mice. J. Physiol. 571, 319-327.
16. Phuoc, N.B., Ehara, H., Gotoh, T., Nakano, M., Kamei, S., Deguchi, T., Hirose, Y., 2008. Prognostic value of the co-expression of carbonic anhydrase IX and vascular endothelial growth factor in patients with clear cell renal cell carcinoma. Oncol. Rep. 20, 525-530.
17. Prontera, C., Mariani, B., Rossi, C., Poggi, A., Rotilio, D., 1999. Inhibition of gelatinase A (MMP-2) by batimastat and captopril reduces tumor growth and lung metastases in mice bearing Lewis lung carcinoma. Int. J. Cancer 81, 761-766. (Pubitemid 29214387)
18. Saitoh, Y., Kuratsu, J., Takeshima, H., Yamamoto, S., Ushio, Y., 1995. Expression of osteopontin in human glioma. Its correlation with the malignancy. Lab. Invest. 72, 55-63.
19. Shijubo, N., Kojima, H., Nagata, M., Ohchi, T., Suzuki, A., Abe, S., Sato, N., 2003. Tumor angiogenesis of non-small cell lung cancer. Microsc. Res. Tech. 60, 186-198.
20. Takahashi, F., Akutagawa, S., Fukumoto, H., Tsukiyama, S., Ohe, Y., Takahashi, K., Fukuchi, Y., Saijo, N., Nishio, K., 2002. Osteopontin induces angiogenesis of murine neuroblastoma cells in mice. Int. J. Cancer 98, 707-712. (Pubitemid 34225620)
21. Tang, H., Wang, J., Bai, F., Hong, L., Liang, J., Gao, J., Zhai, H., Lan, M., Zhang, F., Wu, K., Fan, D., 2007. Inhibition of osteopontin would suppress angiogenesis in gastric cancer. Biochem. Cell. Biol. 85, 103-110.
22. Ustundag, N., Bozkurt, A.K., Demirkaya, A., Koksal, C., Mayda, A.S., 2004. Histopathological and immunohistochemical detection of protective effects of University of Wisconsin solution supplemented with iloprost on donor lung damage. Transplant Proc. 36, 1271-1274. (Pubitemid 38902955)
23. van Breemen, M.S., Wilms, E.B., Vecht, C.J., 2007. Epilepsy in patients with brain tumours: epidemiology, mechanisms, and management. Lancet Neurol. 6, 421-430. (Pubitemid 46551867)
24. Vullo, D., Innocenti, A., Nishimori, I., Pastorek, J., Scozzafava, A., Pastoreková, S., Supuran, C.T., 2005. Carbonic anhydrase inhibitors. Inhibition of the transmembrane isozyme XII with sulfonamides-a new target for the design of antitumor and antiglaucoma drugs? Bioorg. Med. Chem. Lett. 5, 963-969.
25. Winum, J.Y., Cecchi, A., Montero, J.L., Innocenti, A., Scozzafava, A., Supuran, C.T., 2005a. Carbonic anhydrase inhibitors. Synthesis and inhibition of cytosolic/tumor-associated carbonic anhydrase isozymes I, II, and IX with boron-containing sulfonamides, sulfamides, and sulfamates: toward agents for boron neutron capture therapy of hypoxic tumors. Bioorg. Med. Chem. Lett. 15, 3302-3306.
26. Winum, J.Y., Scozzafava, A., Montero, J.L., Supuran, C.T., 2005b. Sulfamates and their therapeutic potential. Med. Res. Rev 25, 186-228.
27. Xiang, Y., Ma, B., Li, T., Yu, H.M., Li, X.J., 2002. Acetazolamide suppresses tumor metastasis and related protein expression in mice bearing Lewis lung carcinoma. Acta Pharmacol. Sin. 23, 745-751.
28. Xiang, Y., Ma, B., Yu, H.M., Li, X.J., 2004. The protein profile of acetazolamide-treated sera in mice bearing Lewis neoplasm. Life Sci. 75, 1277-1285. (Pubitemid 38845027)